We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

By HospiMedica International staff writers
Posted on 29 Sep 2026

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy. More...

Even when blood samples are rushed to the laboratory, results can take up to an hour, delaying time-sensitive decisions. Researchers have now developed a bedside blood test that can measure drug concentrations in under 10 minutes and support faster treatment decisions.

Aarhus University’s (Aarhus, Denmark) Department of Chemistry developed the point-of-care system, which combines a small disposable cassette with a compact optical reader. A blood sample is applied directly to the cassette without prior treatment. Inside the cassette, an integrated filter retains blood cells while allowing plasma to flow into a measurement chamber.

The method uses pre-dried chemical and biological reagents embedded in the filter. When plasma reaches the filter, these reagents dissolve and initiate the reaction. Specific antibodies and optical measurement technology then generate a signal that the reader analyzes to automatically calculate the precise drug concentration.

The technology was evaluated using blood samples from 52 patients treated at hospitals in Denmark and abroad. Results closely matched those from traditional central laboratory instruments, while reducing analysis time to under 10 minutes and eliminating the need for centrifugation or manual laboratory processing.

The study focused initially on three anticoagulants: dabigatran, rivaroxaban, and apixaban. It also tested the cancer drug methotrexate and the antibiotic linezolid. The work was published in ACS Sensors under the title “A Point-of-Care System for the Quantification of Small-Molecule Drugs in Blood.” MedicQuant, a spinout company founded in 2019, is further developing and manufacturing the technology.

The developers said the compact instrument could be placed in smaller hospitals or local clinics, reducing the need to transport patients or samples over long distances for urgent testing. They also indicated that the approach may be applicable to other critical drug measurements, including immunosuppressive medicines and antibiotics. The main challenges described were bringing the technology into practical use, maturing the market, and adapting clinical workflows.

“Time is everything when dealing with a stroke. The longer an area of the brain goes without oxygen, the higher the risk of tissue death and brain damage. Therefore, acting quickly is vital, and this solution can shave off crucial minutes and provide a significantly better outcome for the patient,” said Kurt Vesterager Gothelf, chemistry professor and head of the research group.

Related Links
Aarhus University


Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Patient Preoperative Skin Preparation
BD ChloraPrep
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Fluorescence image of water-acetone mixture condensation. (Photo courtesy of Jingcheng Ma/Interfacial Thermofluids Laboratory)

New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring

Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.